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these hospitalizations, and in 26.4% of patients. Among all hospitalizations, not
having an HbA1c test in the previous 3 months was associated with twice the rate
of those with a previous test (32.4% vs 16.2%), and hospitalizations with glucose
values of 200 mg/dl or greater had a higher rate (27.7%) than did those with lower
glucose levels (18.3%). Endocrinologist treatment during a hospitalization was as-
sociated with a higher HbA1c utilization rate (43.6%) compared to treatment from
all other specialties (23.3%), including hospital medicine (21.1%). Among all pa-
tients, younger patients had a higher HbA1c utilization rate than did patients65
years (47.2% 21, 29.5% 21-64, and 23.8% 65), as did male patients (28.3% vs
24.5%). Type 1 diabetics had a higher rate than did patients with pre-diabetes/
undiagnosed diabetes and type 2 diabetes (32.0%, 28.7%, and 25.4%, respectively).
Among hospitalizations of pre-diabetes/undiagnosed patients who received an
HbA1c test, 17.9% had values of 6.5% or greater.CONCLUSIONS:These data suggest
that overall utilization of HbA1c tests in the hospital setting is low among pre-
diabetic/undiagnosed and diabetic patients with hyperglycemia. The utilization
rate differs significantly by patient characteristics and by physician specialty.
These data highlight the potential to improve identification and diagnosis of dia-
betes within the hospital setting.
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OBJECTIVES: In our earlier cross-sectional analyses of physician involvement in
health care provision for patients with a diagnosis of ADHD (for year 2003), we
observed that only 36% of children and adolescents and 33.5% of adults had been
seen by a CNS specialist. The present study revisits health care provision for ADHD
patients by physician group.METHODS: Patient-level data were extracted for anal-
ysis from the physician-centered claims database of the Kassenaerztliche Vereini-
gung (KV) in Nordbaden / Germany, which covers the entire regional population
enrolled in statutory health insurance (2.2 million lives). For calendar year 2009,
21,287 patients with ADHD [“hyperkinetic disorder”, HKD; ICD-10 codes F90.0 or
F90.1] (male, 15,108; female, 6,179; including 5,931 patients or 27.9% [male, 4,582;
female, 1,349] with coexisting conduct disorder [HKCD; F90.1 or a combination of
F90 and F91]) were available for analysis of health care provider contacts. RESULTS:
Overall, the rate of ADHD patients seen at least once by a CNS specialist (physician)
increased from 42.0% in 2003 to 49.1% in 2009; the rate of those seen at least twice
during the calendar year increased from 26.4% to 33.2% (for age group 0-5 years,
from 9.1% to 11.1%; 6-12 years, from 27.4% to 33.7%, 13-17 years, from 30.3% to
33.1%, 18 years, from 26.4% to 33.2%. Patients with HKCD were more likely to be
seen by CNS specialists than patients with HKD only. Most children (in 2009, 84.4%)
and adolescents (61.0%) were seen at least once by a pediatrician. The rate of
patients seen by psychotherapists remained stable at 10%. Within provider
groups, health care for patients with ADHD was highly concentrated. Each child
and adolescent psychiatrist treated, on average, 231 patients with ADHD.
CONCLUSIONS: Despite a moderate increase since 2003, CNS specialist involve-
ment in health care provision for patients with ADHD remains relatively low.
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OBJECTIVES: To study the rate of suicidality and factors related to the Thai people.
METHODS: Nationally representative face to face household survey based on a
stratified clustered sampling of people aging 15 to 59 (n  17,140). The data were
conducted between June and August 2008 using Mini International Neuropsychi-
atric Interview (M.I.N.I.) module C. Suicidality and general information question-
naire by trained psychiatric professionals. The data analysis was determined by
means adjusted weight of rate generalized to Thai population and analyzed with
descriptive statistical methods by attaining percentage of mean, proportions, stan-
dard errors, population estimation and probability inference from the data.
RESULTS: The overall national rate of suicidality accounted for 7.3%, the severity
risk of suicide was found mild 6.0%, moderate 0.6% and severe 0.7%. The highest
risk of suicide was found in the north (8.8%, severe degree 1.3%) females (8.6%), age
of 35 to 44 (8.1%), separated, divorced or widowed (11.8%), being unemployed
(13.8%), mood disorders with psychotic features (87.9%), current manic episode
(64.3%). CONCLUSIONS: For effective surveillance and prevention of suicide in
Thailand’s population, the focus should be on the population of Northern prov-
inces, females, those in productive age, being unemployed and those concurrently
having mental disorders particulary, mood disorders.
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OBJECTIVES: To evaluate the implementation of National Institute for Health and
Clinical Excellence (NICE) guidance across four hospitals in the NHS South of Eng-
land region, and its impact on patient safety using the following outcome mea-
sures: The percentage of patients for whom a risk assessment was documented;
the percentage of patients who received venous thromboembolism (VTE) prophy-
laxis amongst those who were not risk assessed and the percentage of patients
who received VTE prophylaxis amongst those with a contraindication to VTE
prophylaxis. METHODS: A mixed method approach, which included a retrospec-
tive patient record review of VTE risk assessment documentation and prescribing
of prophylaxis in patients without a risk assessment or a documented contraindi-
cation to VTE prophylaxis prior to and following the implementation of NICE guid-
ance. Qualitative methods in the form of semi-structured interviews were used to
evaluate the implementation strategies employed by the four hospitals. RESULTS:
The percentage of patients for whom a VTE risk assessment was documented
increased from 51.5% (210/408) in 2009 to 79.2% (323/408) in 2010; difference 27.7%
(95% CI: 21.4% to 33.9%; p0.001). There was little evidence of change in the per-
centage who were prescribed prophylaxis amongst patients without a risk assess-
ment (71.7% (142/198) in 2009 and 68.2% (58/85) in 2010; difference -3.5%% (95% CI:
-15.2% to 8.2%; p 0.56) nor the percentage who were prescribed low molecular
weight heparin amongst patients with a contraindication (14% (4/28) in 2009 and
15% (6/41) in 2010; RD 0.3% (95% CI: -16.5% to 17.2%; p0.97).CONCLUSIONS: The
documentation of risk assessment clearly improved following the implementation
of NICE guidance but this did not lead to improved patient safety in terms of
increasing appropriate or decreasing inappropriate prescribing of prophylaxis.
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OBJECTIVES: To develop an off-the-shelf catalogue of quality improvement (QI)
interventions to implement for preventing hospital-acquire pressure ulcers (HA-
PUs). In 2007, the Institute of Healthcare Improvement (IHI) released a 17-item
best-practice framework of general QI interventions organized into four domains
of hospital practice: Leadership; Staff; Information & Information Technology; and
Performance & Improvement. Since HAPU prevention has become a burgeoning
international topic because of its monetary burden on health care, clinicians have
investigated novel methods to bolster HAPU prevention guidelines. QI interven-
tions pose a promising resource for improved HAPU outcomes.METHODS: Starting
with the IHI best-practice framework, fourteen leading experts in QI and HAPU
prevention at academic tertiary care facilities were interviewed in-person to qual-
itatively augment the list of QI interventions to reflect HAPU-specific preventive QI
interventions. The respondents possessed backgrounds as physicians (6), wound
care nurses (4), QI experts (2), and outcomes researchers (2). Interviews followed a
structured outline of the best-practice framework, in which they were allowed to
add, delete or modify QI interventions within each domain as they pertained to
HAPU prevention. RESULTS: The series of qualitative interviews resulted in suc-
cessful augmentation to IHI’s best-practice framework of QI interventions to more
accurately reflect current practice in HAPU prevention. The HAPU-practice frame-
work contains seven Leadership items, six Staff items, four Information & Infor-
mation Technology items, and eight Performance & Improvement items. Of these
items, four were removed from the original framework, twelve were added, and all
remaining items were modified in some manner. CONCLUSIONS: This qualitative
study provides an off-the-shelf catalogue of QI interventions that wound care
teams can utilize for preventing HAPUs and possibly other hospital-acquired con-
ditions. For further consideration, the field would benefit from comparative effec-
tiveness research about QI interventions and strategies for HAPU prevention that
hospitals can then focus their efforts toward.
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OBJECTIVES: We documented the clinical characteristics, treatment patterns, and
resource utilization associated with diverticulitis in a real-world European
population.METHODS:Data were abstracted from medical charts of 1,509 patients
in 5 countries (300 per country): UK, Germany, France, The Netherlands, and
Spain. Inclusion criteria were: diagnosed with diverticulitis during Jnuary 1, 2007–
September 30, 2010; aged 18 years at first (index) diagnosis; no history of colon
cancer; not enrolled in diverticulitis-related clinical trial; and 12 months of chart
history after index diagnosis. Study measures were evaluated over all available
post-index follow-up (12 months). RESULTS: Mean [SD] age at index was 61.7
[11.2] years and 55% of patients were male. Diagnosis setting was evenly distrib-
uted by general practitioner (29%), specialist (24%), emergency (24%), and hospital
(22%). Diabetes was the most common chronic comorbidity (23% of patients) and
20% of patients were considered obese. More than half of patients presented with
or subsequently developed diverticulitis-related complications, most commonly
fissure/abscess/fistula (23%) or lower gastrointestinal (GI) hemorrhage (14%). Peri-
tonitis, a life-threatening infection, was seen in 8.4% of patients. One-fifth (20%)
of patients did not receive antibiotics or other pharmacotherapies (i.e., amin-
osalicylates, analgesics, other GI drugs) used to manage diverticulitis and its symp-
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toms. Among patients managed by office-based physicians (n753), oral antibiot-
ics and aminosalicylates (72% and 68% of patients, respectively) were the common
treatments. Among those managed by hospital-based physicians (n756), amin-
osalicylates were infrequently prescribed (11% of patients) and intravenous anti-
biotics were preferred over oral (67% and 36%, respectively). Fifty-seven percent of
patients were hospitalized, with the majority being for acute disease management
or diagnostics. Among those hospitalized, mean [SD] length of stay was 12.6 [31.8]
days. CONCLUSIONS: Diverticulitis presents a significant disease burden to health
care systems and patients in Europe. Many patients with diverticulitis present with
or develop serious complications, leading to frequent hospitalization and long hos-
pital stays.
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Spontaneous reporting of adverse drug reactions (ADRs) by health care staff using
the respective ADR reporting forms plays the key role in the Pharmacovigilance
system of various countries. Under-reporting of ADRs is a serious public health
issue. Occurrence of ADR varies from people to people and country to country. In
any given country, the ADR reporting form holds the key to collect vital ADR related
information. But, the structure and content of this form vary widely from country
to country.OBJECTIVES:The present study involved the collection and comparison
of ADR reporting forms of 55 different countries. METHODS: We analyzed the
uniformity of the forms by identifying 25 critical reporting parameters that assure
drug safety and ensure the casualty relationship between the drug and the ADR.
The non-English forms were translated using Google Translate. RESULTS: It re-
vealed through our study that only 8 out of 55 countries (14.5%) had at least 75% of
the parameters covered in their form. The ADR reporting form of Ukraine was
found to have 20 parameters (80%) covered. Following that, the ADR reporting
forms of India, Republic of China, and Malaysia covered 19 parameters (76%). Many
countries lack vital information about the patient. CONCLUSIONS: This study has
helped to identify the lack of information. There should be internationally recog-
nized uniform guidelines and checklists for designing of spontaneous reporting
forms. Though there are differences between the countries in gathering informa-
tion about suspected ADRs, the drug safety data from each country ultimately goes
to one single database – Vigibase. The reporting system and the forms used in most
of the developing nations should be improved, which in turn improves the quality
use of medicines in the respective country.
PIH2
DULOXETINE USE IN PREGNANCY: A PROSPECTIVE, COMPARATIVE STUDY OF
EXPOSED INFANTS
Einarson A1, Koren G1, Einarson TR2
1The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada, 2University of
Toronto, Toronto, ON, Canada
OBJECTIVES: 1) To determine whether the use of duloxetine during pregnancy is
associated with an increased risk for major malformations; 2) examine rates of
spontaneous abortions(SA), therapeutic abortions(TA), stillbirths, as well as mean
birth-weight and gestational age at delivery; and 3) examine rates of Poor Neonatal
Adaptation Syndrome (PNAS) following late pregnancy exposure. METHODS: Data
was collected from either women or their health care providers who had requested
information regarding the use of duloxetine during pregnancy. The study design
was prospective, with two comparison groups, 1) exposed to other antidepressants,
and 2) exposed to non-teratogens (NTC). RESULTS: We completed 624 pregnancy
outcomes which included 208 in each group. Rates of major malformations were
similar across groups (p0.992). Significant differences were noted only in rates of
spontaneous abortions (p0.011) and admissions to neonatal intensive care unit/
special care nursery (p0.010). There were more preterm births in the duloxetine
group, although the results were not statistically different. There were 3/53 (5.6%)
cases consistent with PNAS symptoms in the duloxetine group with no evidence of
a dose response.CONCLUSIONS:Duloxetine does not appear to increase the rate of
major malformations above baseline. The higher rate of SA corroborates similar
results from other studies of antidepressant use in pregnancy. The incidence of
symptoms of PNAS in our study is somewhat lower than in prior studies reporting
on this outcome. These data add to the information regarding SNRI use in preg-
nancy, which will enable a woman, together with her physician, to make an evi-
dence-based decision regarding the use of duloxetine.
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OBJECTIVES: The University of Michigan Women’s Registry database contains in-
formation on 2,771 women. In addition to menopause diagnoses, the database
contains demographic characteristic, body mass index (BMI), menopause symp-
tom, hormone therapy, surgery, and other comorbidity information. This study
aims to compare the demographic and clinical characteristics between women
diagnosed with menopause versus those who were not, and explore the relation-
ship between menopause symptoms and diagnosis. METHODS: Demographic and
clinical characteristics between women diagnosed with menopause and those who
were not were compared descriptively. Mean and standard deviation were calcu-
lated for continuous variables, and numbers and percentages were calculated for
binary or categorical variables. T-test and Chi-square test were used to calculate
the p-values. RESULTS: Among all women in the registry (mean BMI: 29), 16%
(N443) were menopausal. Of this subset, 53.5% (N237) were treated with hor-
mone therapy. Hormone therapies included estrogen and progesterone combined
(58.67%), estrogen only (35.11%), soy/herbal remedies (4%), and raloxifene (2.22%).
For women with at least one menopausal symptom (N349), the most common
were hot flashes (59.60%) and vaginal dryness (59.60%). Non-menopausal women
were more likely to have hot flashes (66.67% vs. 49.76%, p-value0.007), mood
swings (56.06% vs. 25.12%, p-value0.001) and memory loss (55.30% vs. 39.23%,
p-value0.001) than menopausal women, which indicates that the menopause
diagnosis may be underestimated. This is consistent with the common issue found
in claims data, that menopausal women are not always diagnosed by physicians.
CONCLUSIONS: Women not diagnosed with menopause frequently had more
menopausal symptoms than women with diagnosed menopause. This may indi-
cate the underestimation of diagnosis. Therefore, it would be beneficial to use
menopausal symptoms as proxies to the diagnosis and control for them in the
research model. Techniques such as probabilistic linkage, could bridge the gap
between information in claims and registry data.
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In 2010, NICE published a clinical guideline on reducing the risk of venous throm-
boembolism (VTE) in patients admitted to hospital. At the time, five pharmological
VTE prophylaxis were recommended following elective knee or hip replacement
surgery—dabigatran etexilate, fondaparinux sodium, low molecular weight hepa-
rin (LMWH), rivaroxaban, and unfractionated heparin (UFH) for patients with renal
failure—in 2011, apixaban was also recommended for the same indication in the
UK. Although apixaban, dabigatran, and rivaroxaban were all assessed at different
times by NICE, each technology appraisal used a distinct methodology to compare
relevant interventions, directly and indirectly.OBJECTIVES:To evaluate the impact
of study identification methods and network size on indirect and mixed treatment
comparisons of pharmacological interventions for the prevention of VTE in pa-
tients undergoing elective orthopaedic surgery.METHODS:Data identification and
synthesis methods used in the NICE TA157, TA170, and TA245 were reviewed and
compared to best practice searching strategies and network meta-analysis meth-
odology. Literature searches specifically designed to collect data for use in network
meta-analysis were conducted and compared to original search results. Various
network sizes were tested to synthesise available evidence using Winbugs.
PRELIMINARY. RESULTS: Specifically designed search strategies to inform the ev-
idence base for network meta-analysis led to increased numbers of studies identi-
fied and included for synthesis increasing the total number of indirect comparisons
between existing VTE interventions. The impact of additional comparisons on rel-
ative treatment estimates was limited and precision did not increase.
CONCLUSIONS: Using a specific search strategy designed to optimise the identifi-
cation of studies for network meta-analysis allowed us to extend the network of
relevant studies; however, extending the network increased uncertainty in the
results and led to inconsistencies in the direct and indirect comparisons.
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OBJECTIVES: Countless studies have demonstrated that many emergency-room
visits and hospital admissions are drug-related and that a significant proportion of
these drug-related visits (DRV) are preventable. It has not been previously studied
which DRVs could be prevented through enhanced monitoring of therapy. The
objective of the study was to determine the incidence of DRVs attributed to labo-
ratory or physiologic abnormalities. METHODS: Three authors independently per-
formed comprehensive searches in relevant health care databases using pre-de-
termined search terms. Articles discussing DRV associated with poisoning,
substance abuse, or studied among existing in-patient populations were excluded.
Study country, year, sample, design, duration, DRV identification method, propor-
tion of DRVs associated with laboratory or physiologic abnormalities and associ-
ated medications were extracted. The three authors independently assessed se-
lected relevant articles according to the Strengthening the reporting of
observational studies in epidemiology (STROBE) and Consolidted Standards of Re-
porting Trials (CONSORT) guides as applicable according to the studies’
methodology. RESULTS: The initial literature search yielded a total of 1,780 articles
of which 43 articles meeting inclusion criteria and reporting sufficient laboratory or
physiologic data were included in the overall analysis. Half (52%) employed pro-
spective methodologies, which included both chart review and patient interview;
however, the overwhelming majorityof identified studies assessed only adverse
drug reactions (ADR) as a drug-related cause for DRV. Among the 43 studies, re-
ported DRV ranged between 0.4% and 40.9%, of which an association with labora-
tory or physiologic abnormalities represented 0.8% - 69.7% of cases. Most labora-
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